Skip to main content

Advertisement

SpringerLink
Log in

Pediatric diffuse intrinsic pontine glioma: where do we stand?

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Pediatric diffuse intrinsic pontine glioma (DIPG) represents approximately 20% of all pediatric CNS tumors. However, disease outcomes are dismal with a median survival of less than 1 year and a 2-year overall survival rate of less than 10%. Despite extensive efforts to improve survival outcomes, progress towards clinical improvement has been largely stagnant throughout the last 4 decades. Focal radiotherapy remains the standard of care with no promising single-agent alternatives and no evidence for improvement with the addition of a long list of systemic therapies. A better understanding of the biology of DIPG, though not easy due to obstacles in obtaining pathological material to study, is promising for the development of specific individualized treatment for this fatal disease. Recent studies have found epigenetic mutations to be successful predictors and prognostic factors for developing future management policies. The aim of this review is to give a global overview about the epidemiology, diagnosis, and treatment of DIPG. We further examine the controversial biopsy and autopsy issue that is unique to DIPG and assess the subsequent impact this issue has on the research efforts and clinical management of DIPG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hassan, H., Pinches, A., Picton, S. V., & Phillips, R. S. (2017). Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis. Journal of Neuro-Oncology, 135, 1–8. https://doi.org/10.1007/s11060-017-2546-1.

    Article  Google Scholar 

  2. Saratsis, A. M., Kambhampati, M., Snyder, K., Yadavilli, S., Devaney, J. M., Harmon, B., Hall, J., Raabe, E. H., An, P., Weingart, M., Rood, B. R., Magge, S. N., MacDonald, T., Packer, R. J., & Nazarian, J. (2014). Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathologica, 127(6), 881–895. https://doi.org/10.1007/s00401-013-1218-2.

    Article  CAS  PubMed  Google Scholar 

  3. Barkovich, A. J., Krischer, J., Kun, L. F., Packer, R., Zimmerman, R. A., Freeman, C. R., et al. (1990). Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatric Neurosurgery, 16(2), 73–83. https://doi.org/10.1159/000120511.

    Article  PubMed  Google Scholar 

  4. Bartels, U., Hawkins, C., Vézina, G., Kun, L., Souweidane, M., & Bouffet, E. (2011). Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. Journal of Neuro-Oncology, 105(1), 119–125. https://doi.org/10.1007/s11060-011-0704-4.

    Article  PubMed  Google Scholar 

  5. Smith, M. A., Freidlin, B., Ries, L. A., & Simon, R. (1998). Trends in reported incidence of primary malignant brain tumors in children in the United States. Journal of the National Cancer Institute, 90(17), 1269–1277 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9731733.

    Article  CAS  PubMed  Google Scholar 

  6. Hargrave, D., Bartels, U., & Bouffet, E. (2006). Diffuse brainstem glioma in children: critical review of clinical trials. The Lancet Oncology, 7(3), 241–248. https://doi.org/10.1016/S1470-2045(06)70615-5.

    Article  PubMed  Google Scholar 

  7. Buczkowicz, P., Bartels, U., Bouffet, E., Becher, O., & Hawkins, C. (2014). Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathologica, 128(4), 573–581. https://doi.org/10.1007/s00401-014-1319-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Landolfi, J. C., Thaler, H. T., & DeAngelis, L. M. (1998). Adult brainstem gliomas. Neurology, 51(4), 1136–1139 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9781543.

    Article  CAS  PubMed  Google Scholar 

  9. Recinos, P. F., Sciubba, D. M., & Jallo, G. I. (2007). Brainstem tumors: where are we today? Pediatric Neurosurgery, 43(3), 192–201. https://doi.org/10.1159/000098831.

    Article  PubMed  Google Scholar 

  10. Freeman, C. R., & Farmer, J. P. (1998). Pediatric brain stem gliomas: a review. International Journal of Radiation Oncology, Biology, Physics, 40(2), 265–271. https://doi.org/10.1016/s0360-3016(97)00572-5.

    Article  CAS  PubMed  Google Scholar 

  11. Lassiter, K. R. L., Alexander, E., Davis, C. H., & Kelly, D. L. (1971). Surgical treatment of brain stem gliomas. Journal of Neurosurgery, 34(6), 719–725. https://doi.org/10.3171/jns.1971.34.6.0719.

    Article  CAS  PubMed  Google Scholar 

  12. Warren, K. E. (2012). Diffuse intrinsic pontine glioma: poised for progress. Frontiers in Oncology, 2, 205. https://doi.org/10.3389/fonc.2012.00205.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Robison, N. J., & Kieran, M. W. (2014). Diffuse intrinsic pontine glioma: a reassessment. Journal of Neuro-Oncology, 119(1), 7–15. https://doi.org/10.1007/s11060-014-1448-8.

    Article  CAS  PubMed  Google Scholar 

  14. Bradley, K. A., Zhou, T., McNall-Knapp, R. Y., Jakacki, R. I., Levy, A. S., Vezina, G., & Pollack, I. F. (2013). Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children’s Oncology Group phase 2 study. International Journal of Radiation Oncology, Biology, and Physics, 85(1), e55–e60. https://doi.org/10.1016/j.ijrobp.2012.09.004.

    Article  CAS  Google Scholar 

  15. Angelini, P., Hawkins, C., Laperriere, N., Bouffet, E., & Bartels, U. (2011). Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances. Journal of Neuro-Oncology, 101(1), 75–81. https://doi.org/10.1007/s11060-010-0224-7.

    Article  PubMed  Google Scholar 

  16. Albright, A. L., Packer, R. J., Zimmerman, R., Rorke, L. B., Boyett, J., & Hammond, G. D. (1993). Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery, 33(6), 1026–1029 discussion 1029-30. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8133987.

    CAS  PubMed  Google Scholar 

  17. Schumacher, M., Schulte-Mönting, J., Stoeter, P., Warmuth-Metz, M., & Solymosi, L. (2007). Magnetic resonance imaging compared with biopsy in the diagnosis of brainstem diseases of childhood: a multicenter review. Journal of Neurosurgery: Pediatrics, 106(2), 111–119. https://doi.org/10.3171/ped.2007.106.2.111.

    Article  Google Scholar 

  18. Plessier, A., Le Dret, L., Varlet, P., Beccaria, K., Lacombe, J., Mériaux, S., et al. (2017). New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis. Oncotarget, 8(32), 52543–52559. https://doi.org/10.18632/oncotarget.15002.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sewing, A. C. P., Lagerweij, T., van Vuurden, D. G., Meel, M. H., Veringa, S. J. E., Carcaboso, A. M., et al. (2017). Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Journal of Neurosurgery: Pediatrics, 19(5), 518–530. https://doi.org/10.3171/2016.9.PEDS16152.

    Article  PubMed  Google Scholar 

  20. Misuraca, K. L., Cordero, F. J., & Becher, O. J. (2015). Pre-clinical models of diffuse intrinsic pontine glioma. Frontiers in Oncology, 5, 172. https://doi.org/10.3389/fonc.2015.00172.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lapin, D. H., Tsoli, M., & Ziegler, D. S. (2017). Genomic insights into diffuse intrinsic pontine glioma. Frontiers in Oncology, 7, 57. https://doi.org/10.3389/fonc.2017.00057.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kambhampati, M., Perez, J. P., Yadavilli, S., Saratsis, A. M., Hill, A. D., Ho, C.-Y., et al. (2015). A standardized autopsy procurement allows for the comprehensive study of DIPG biology. Oncotarget, 6(14), 12740–12747. https://doi.org/10.18632/oncotarget.3374.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Caretti, V., Jansen, M. H. A., van Vuurden, D. G., Lagerweij, T., Bugiani, M., Horsman, I., et al. (2013). Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture. Neuropathology and Applied Neurobiology, 39(4), 426–436. https://doi.org/10.1111/j.1365-2990.2012.01294.x.

    Article  CAS  PubMed  Google Scholar 

  24. Puget, S., Beccaria, K., Blauwblomme, T., Roujeau, T., James, S., Grill, J., et al. (2015). Biopsy in a series of 130 pediatric diffuse intrinsic pontine gliomas. Child's Nervous System, 31(10), 1773–1780. https://doi.org/10.1007/s00381-015-2832-1.

    Article  PubMed  Google Scholar 

  25. Cage, T. A., Samagh, S. P., Mueller, S., Nicolaides, T., Haas-Kogan, D., Prados, M., Banerjee, A., Auguste, K. I., & Gupta, N. (2013). Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children. Child's Nervous System, 29(8), 1313–1319. https://doi.org/10.1007/s00381-013-2101-0.

    Article  PubMed  Google Scholar 

  26. Hamisch, C., Kickingereder, P., Fischer, M., Simon, T., & Ruge, M. I. (2017). Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. Journal of Neurosurgery: Pediatrics, 20(3), 261–268. https://doi.org/10.3171/2017.2.PEDS1665.

    Article  PubMed  Google Scholar 

  27. Pfaff, E., El Damaty, A., Balasubramanian, G. P., Blattner-Johnson, M., Worst, B. C., Stark, S., et al. (2019). Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. European Journal of Cancer, 114, 27–35. https://doi.org/10.1016/j.ejca.2019.03.019.

    Article  PubMed  Google Scholar 

  28. Gupta, N., Goumnerova, L. C., Manley, P., Chi, S. N., Neuberg, D., Puligandla, M., Fangusaro, J., Goldman, S., Tomita, T., Alden, T., DiPatri, A., Rubin, J. B., Gauvain, K., Limbrick, D., Leonard, J., Geyer, J. R., Leary, S., Browd, S., Wang, Z., Sood, S., Bendel, A., Nagib, M., Gardner, S., Karajannis, M. A., Harter, D., Ayyanar, K., Gump, W., Bowers, D. C., Weprin, B., MacDonald, T., Aguilera, D., Brahma, B., Robison, N. J., Kiehna, E., Krieger, M., Sandler, E., Aldana, P., Khatib, Z., Ragheb, J., Bhatia, S., Mueller, S., Banerjee, A., Bredlau, A. L., Gururangan, S., Fuchs, H., Cohen, K. J., Jallo, G., Dorris, K., Handler, M., Comito, M., Dias, M., Nazemi, K., Baird, L., Murray, J., Lindeman, N., Hornick, J. L., Malkin, H., Sinai, C., Greenspan, L., Wright, K. D., Prados, M., Bandopadhayay, P., Ligon, K. L., & Kieran, M. W. (2018). Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro-Oncology, 20(11), 1547–1555. https://doi.org/10.1093/neuonc/noy070.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Samadani, U., & Judy, K. D. (2003). Stereotactic brainstem biopsy is indicated for the diagnosis of a vast array of brainstem pathology. Stereotactic and Functional Neurosurgery, 81(1–4), 5–9. https://doi.org/10.1159/000075097.

    Article  PubMed  Google Scholar 

  30. Pincus, D. W., Richter, E. O., Yachnis, A. T., Bennett, J., Bhatti, M. T., & Smith, A. (2006). Brainstem stereotactic biopsy sampling in children. Journal of Neurosurgery: Pediatrics, 104(2), 108–114. https://doi.org/10.3171/ped.2006.104.2.108.

    Article  Google Scholar 

  31. Bandopadhayay, P., Greenwald, N. F., Wala, J., Sharpira, O., Tracy, A., Filbin, M., et al. (2017). DIPG-29. Genomic landscape of diffuse intrinsic pontine glioma: an analysis of the DIPG-BATs cohort. Neuro-Oncology, 19(suppl_4), iv11. https://doi.org/10.1093/neuonc/nox083.044.

    Article  PubMed Central  Google Scholar 

  32. Alix-Panabières, C., & Pantel, K. (2016). Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discovery, 6(5), 479–491. https://doi.org/10.1158/2159-8290.CD-15-1483.

    Article  CAS  PubMed  Google Scholar 

  33. Mattox, A. K., Bettegowda, C., Zhou, S., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2019). Applications of liquid biopsies for cancer. Science Translational Medicine, 11(507), eaay1984. https://doi.org/10.1126/scitranslmed.aay1984.

    Article  CAS  PubMed  Google Scholar 

  34. Huang, T. Y., Piunti, A., Lulla, R. R., Qi, J., Horbinski, C. M., Tomita, T., James, C. D., Shilatifard, A., & Saratsis, A. M. (2017). Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathologica Communications, 5(1), 28. https://doi.org/10.1186/s40478-017-0436-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Panditharatna, E., Kilburn, L. B., Aboian, M. S., Kambhampati, M., Gordish-Dressman, H., Magge, S. N., Gupta, N., Myseros, J. S., Hwang, E. I., Kline, C., Crawford, J. R., Warren, K. E., Cha, S., Liang, W. S., Berens, M. E., Packer, R. J., Resnick, A. C., Prados, M., Mueller, S., & Nazarian, J. (2018). Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clinical Cancer Research, 24(23), 5850–5859. https://doi.org/10.1158/1078-0432.CCR-18-1345.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Pan, C., Diplas, B. H., Chen, X., Wu, Y., Xiao, X., Jiang, L., Geng, Y., Xu, C., Sun, Y., Zhang, P., Wu, W., Wang, Y., Wu, Z., Zhang, J., Jiao, Y., Yan, H., & Zhang, L. (2019). Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA. Acta Neuropathologica, 137(2), 297–306. https://doi.org/10.1007/s00401-018-1936-6.

    Article  CAS  PubMed  Google Scholar 

  37. Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., Zuccaro, J., Agnihotri, S., Ryall, S., Barszczyk, M., Chornenkyy, Y., Bourgey, M., Bourque, G., Montpetit, A., Cordero, F., Castelo-Branco, P., Mangerel, J., Tabori, U., Ho, K. C., Huang, A., Taylor, K. R., Mackay, A., Bendel, A. E., Nazarian, J., Fangusaro, J. R., Karajannis, M. A., Zagzag, D., Foreman, N. K., Donson, A., Hegert, J. V., Smith, A., Chan, J., Lafay-Cousin, L., Dunn, S., Hukin, J., Dunham, C., Scheinemann, K., Michaud, J., Zelcer, S., Ramsay, D., Cain, J., Brennan, C., Souweidane, M. M., Jones, C., Allis, C. D., Brudno, M., Becher, O., & Hawkins, C. (2014). Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nature Genetics, 46(5), 451–456. https://doi.org/10.1038/ng.2936.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., Bourgey, M., Bourque, G., Montpetit, A., Bourret, G., Lepage, P., Fleming, A., Lichter, P., Kool, M., von Deimling, A., Sturm, D., Korshunov, A., Faury, D., Jones, D. T., Majewski, J., Pfister, S. M., Jabado, N., & Hawkins, C. (2012). K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathologica, 124(3), 439–447. https://doi.org/10.1007/s00401-012-0998-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., et al. (2012). Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482(7384), 226–231. https://doi.org/10.1038/nature10833.

    Article  CAS  PubMed  Google Scholar 

  40. Wu, G., Broniscer, A., McEachron, T. A., Lu, C., Paugh, B. S., Becksfort, J., et al. (2012). Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nature Genetics, 44(3), 251–253. https://doi.org/10.1038/ng.1102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., Masek, M., Attema, J. L., Li, G., Haddix, T., Edwards, M. S., Fisher, P. G., Weissman, I. L., Rowitch, D. H., Vogel, H., Wong, A. J., & Beachy, P. A. (2011). Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proceedings of the National Academy of Sciences of the United States of America, 108(11), 4453–4458. https://doi.org/10.1073/pnas.1101657108.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Kepert, J. F., Tóth, K. F., Caudron, M., Mücke, N., Langowski, J., & Rippe, K. (2003). Conformation of reconstituted mononucleosomes and effect of linker histone H1 binding studied by scanning force microscopy. Biophysical Journal, 85(6), 4012–4022. https://doi.org/10.1016/S0006-3495(03)74815-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Mariño-Ramírez, L., Kann, M. G., Shoemaker, B. A., & Landsman, D. (2005). Histone structure and nucleosome stability. Expert Review of Proteomics, 2(5), 719–729. https://doi.org/10.1586/14789450.2.5.719.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Carvalho, D., Taylor, K. R., Olaciregui, N. G., Molinari, V., Clarke, M., Mackay, A., Ruddle, R., Henley, A., Valenti, M., Hayes, A., Brandon, A. D. H., Eccles, S. A., Raynaud, F., Boudhar, A., Monje, M., Popov, S., Moore, A. S., Mora, J., Cruz, O., Vinci, M., Brennan, P. E., Bullock, A. N., Carcaboso, A. M., & Jones, C. (2019). ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma. Communications Biology, 2(1), 156. https://doi.org/10.1038/s42003-019-0420-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Castel, D., Philippe, C., Calmon, R., Le Dret, L., Truffaux, N., Boddaert, N., et al. (2015). Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathologica, 130(6), 815–827. https://doi.org/10.1007/s00401-015-1478-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Yuen, B. T. K., & Knoepfler, P. S. (2013). Histone H3.3 mutations: a variant path to cancer. Cancer Cell, 24(5), 567–574. https://doi.org/10.1016/j.ccr.2013.09.015.

    Article  CAS  PubMed  Google Scholar 

  47. Kumar, S. S., Sengupta, S., Lee, K., Hura, N., Fuller, C., DeWire, M., et al. (2017). BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma. Oncotarget, 8(38), 62962–62975. https://doi.org/10.18632/oncotarget.18002.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Han, H. J., Jain, P., & Resnick, A. C. (2018). Shared ACVR1 mutations in FOP and DIPG: opportunities and challenges in extending biological and clinical implications across rare diseases. Bone, 109, 91–100. https://doi.org/10.1016/j.bone.2017.08.001.

    Article  CAS  PubMed  Google Scholar 

  49. Taylor, K. R., Vinci, M., Bullock, A. N., & Jones, C. (2014). ACVR1 mutations in DIPG: lessons learned from FOP. Cancer Research, 74(17), 4565–4570. https://doi.org/10.1158/0008-5472.CAN-14-1298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Taylor, K. R., Mackay, A., Truffaux, N., Butterfield, Y. S., Morozova, O., Philippe, C., et al. (2014). Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nature Genetics, 46(5), 457–461. https://doi.org/10.1038/ng.2925.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Viñals, F., & Ventura, F. (2004). Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1. Journal of Biological Chemistry, 279(44), 45766–45772. https://doi.org/10.1074/jbc.M408059200.

    Article  CAS  PubMed  Google Scholar 

  52. Hoeman, C. M., Cordero, F. J., Hu, G., Misuraca, K., Romero, M. M., Cardona, H. J., et al. (2019). ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nature Communications, 10(1), 1023. https://doi.org/10.1038/s41467-019-08823-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Ségaliny, A. I., Tellez-Gabriel, M., Heymann, M.-F., & Heymann, D. (2015). Receptor tyrosine kinases: characterisation, mechanism of action and therapeutic interests for bone cancers. Journal of bone oncology, 4(1), 1–12. https://doi.org/10.1016/j.jbo.2015.01.001.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Zarghooni, M., Bartels, U., Lee, E., Buczkowicz, P., Morrison, A., Huang, A., et al. (2010). Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor α and poly (ADP-ribose) polymerase as potential therapeutic targets. Journal of Clinical Oncology, 28(8), 1337–1344. https://doi.org/10.1200/JCO.2009.25.5463.

    Article  CAS  PubMed  Google Scholar 

  55. Puget, S., Philippe, C., Bax, D. A., Job, B., Varlet, P., Junier, M.-P., Andreiuolo, F., Carvalho, D., Reis, R., Guerrini-Rousseau, L., Roujeau, T., Dessen, P., Richon, C., Lazar, V., le Teuff, G., Sainte-Rose, C., Geoerger, B., Vassal, G., Jones, C., & Grill, J. (2012). Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One, 7(2), e30313. https://doi.org/10.1371/journal.pone.0030313.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Paugh, B. S., Zhu, X., Qu, C., Endersby, R., Diaz, A. K., Zhang, J., Bax, D. A., Carvalho, D., Reis, R. M., Onar-Thomas, A., Broniscer, A., Wetmore, C., Zhang, J., Jones, C., Ellison, D. W., & Baker, S. J. (2013). Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Research, 73(20), 6219–6229. https://doi.org/10.1158/0008-5472.CAN-13-1491.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Broniscer, A., Baker, S. D., Wetmore, C., Pai Panandiker, A. S., Huang, J., Davidoff, A. M., Onar-Thomas, A., Panetta, J. C., Chin, T. K., Merchant, T. E., Baker, J. N., Kaste, S. C., Gajjar, A., & Stewart, C. F. (2013). Phase I Trial, Pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma. Clinical Cancer Research, 19(11), 3050–3058. https://doi.org/10.1158/1078-0432.CCR-13-0306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Pollack, I. F., Jakacki, R. I., Blaney, S. M., Hancock, M. L., Kieran, M. W., Phillips, P., Kun, L. E., Friedman, H., Packer, R., Banerjee, A., Geyer, J. R., Goldman, S., Poussaint, T. Y., Krasin, M. J., Wang, Y., Hayes, M., Murgo, A., Weiner, S., & Boyett, J. M. (2007). Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report1. Neuro-Oncology, 9(2), 145–160. https://doi.org/10.1215/15228517-2006-031.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Hoeman, C., Shen, C., & Becher, O. J. (2018). CDK4/6 and PDGFRA signaling as therapeutic targets in diffuse intrinsic pontine glioma. Frontiers in Oncology, 8, 191. https://doi.org/10.3389/fonc.2018.00191.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Paugh, B. S., Broniscer, A., Qu, C., Miller, C. P., Zhang, J., Tatevossian, R. G., Olson, J. M., Geyer, J. R., Chi, S. N., da Silva, N. S., Onar-Thomas, A., Baker, J. N., Gajjar, A., Ellison, D. W., & Baker, S. J. (2011). Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. Journal of Clinical Oncology, 29(30), 3999–4006. https://doi.org/10.1200/JCO.2011.35.5677.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Guglielmi, L., Cinnella, C., Nardella, M., Maresca, G., Valentini, A., Mercanti, D., et al. (2014). MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells. Cell Death & Disease, 5(2), e1081–e1081. https://doi.org/10.1038/cddis.2014.42.

    Article  CAS  Google Scholar 

  62. Wu, G., Diaz, A. K., Paugh, B. S., Rankin, S. L., Ju, B., Li, Y., Zhu, X., Qu, C., Chen, X., Zhang, J., Easton, J., Edmonson, M., Ma, X., Lu, C., Nagahawatte, P., Hedlund, E., Rusch, M., Pounds, S., Lin, T., Onar-Thomas, A., Huether, R., Kriwacki, R., Parker, M., Gupta, P., Becksfort, J., Wei, L., Mulder, H. L., Boggs, K., Vadodaria, B., Yergeau, D., Russell, J. C., Ochoa, K., Fulton, R. S., Fulton, L. L., Jones, C., Boop, F. A., Broniscer, A., Wetmore, C., Gajjar, A., Ding, L., Mardis, E. R., Wilson, R. K., Taylor, M. R., Downing, J. R., Ellison, D. W., Zhang, J., & Baker, S. J. (2014). The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nature Genetics, 46(5), 444–450. https://doi.org/10.1038/ng.2938.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Plass, C., Pfister, S. M., Lindroth, A. M., Bogatyrova, O., Claus, R., & Lichter, P. (2013). Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nature Reviews Genetics, 14(11), 765–780. https://doi.org/10.1038/nrg3554.

    Article  CAS  PubMed  Google Scholar 

  64. Grill, J., Puget, S., Andreiuolo, F., Philippe, C., MacConaill, L., & Kieran, M. W. (2012). Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. Pediatric Blood & Cancer, 58(4), 489–491. https://doi.org/10.1002/pbc.24060.

    Article  Google Scholar 

  65. Kleiblova, P., Shaltiel, I. A., Benada, J., Ševčík, J., Pecháčková, S., Pohlreich, P., Voest, E. E., Dundr, P., Bartek, J., Kleibl, Z., Medema, R. H., & Macurek, L. (2013). Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint. The Journal of Cell Biology, 201(4), 511–521. https://doi.org/10.1083/jcb.201210031.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Yagi, H., Chuman, Y., Kozakai, Y., Imagawa, T., Takahashi, Y., Yoshimura, F., et al. (2012). A small molecule inhibitor of p53-inducible protein phosphatase PPM1D. Bioorganic & Medicinal Chemistry Letters, 22(1), 729–732. https://doi.org/10.1016/j.bmcl.2011.10.084.

    Article  CAS  Google Scholar 

  67. Oghabi Bakhshaiesh, T., Majidzadeh-A, K., & Esmaeili, R. (2017). Wip1: a candidate phosphatase for cancer diagnosis and treatment. DNA Repair, 54, 63–66. https://doi.org/10.1016/j.dnarep.2017.03.004.

    Article  CAS  PubMed  Google Scholar 

  68. Giacinti, C., & Giordano, A. (2006). RB and cell cycle progression. Oncogene, 25(38), 5220–5227. https://doi.org/10.1038/sj.onc.1209615.

    Article  CAS  PubMed  Google Scholar 

  69. Paugh, B. S., Qu, C., Jones, C., Liu, Z., Adamowicz-Brice, M., Zhang, J., Bax, D. A., Coyle, B., Barrow, J., Hargrave, D., Lowe, J., Gajjar, A., Zhao, W., Broniscer, A., Ellison, D. W., Grundy, R. G., & Baker, S. J. (2010). Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. Journal of Clinical Oncology, 28(18), 3061–3068. https://doi.org/10.1200/JCO.2009.26.7252.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Warren, K. E., Killian, K., Suuriniemi, M., Wang, Y., Quezado, M., & Meltzer, P. S. (2012). Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro-Oncology, 14(3), 326–332. https://doi.org/10.1093/neuonc/nor190.

    Article  CAS  PubMed  Google Scholar 

  71. Becher, O. J. (2019). CDK4/6 and diffuse intrinsic pontine glioma - evaluate at diagnosis? EBioMedicine, 44, 16–17. https://doi.org/10.1016/j.ebiom.2019.05.020.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Willems, E., Dedobbeleer, M., Digregorio, M., Lombard, A., Lumapat, P. N., & Rogister, B. (2018). The functional diversity of Aurora kinases: a comprehensive review. Cell Division, 13, 7. https://doi.org/10.1186/s13008-018-0040-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Tang, A., Gao, K., Chu, L., Zhang, R., Yang, J., & Zheng, J. (2017). Aurora kinases: novel therapy targets in cancers. Oncotarget, 8(14), 23937–23954. https://doi.org/10.18632/oncotarget.14893.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Buczkowicz, P., Zarghooni, M., Bartels, U., Morrison, A., Misuraca, K. L., Chan, T., Bouffet, E., Huang, A., Becher, O., & Hawkins, C. (2013). Aurora kinase B is a potential therapeutic target in pediatric diffuse intrinsic pontine glioma. Brain Pathology, 23(3), 244–253. https://doi.org/10.1111/j.1750-3639.2012.00633.x.

    Article  CAS  PubMed  Google Scholar 

  75. Matheson, C. J., Backos, D. S., & Reigan, P. (2016). Targeting WEE1 kinase in cancer. Trends in Pharmacological Sciences, 37(10), 872–881. https://doi.org/10.1016/j.tips.2016.06.006.

    Article  CAS  PubMed  Google Scholar 

  76. Geenen, J. J. J., & Schellens, J. H. M. (2017). Molecular pathways: targeting the protein kinase Wee1 in cancer. Clinical Cancer Research, 23(16), 4540–4544. https://doi.org/10.1158/1078-0432.CCR-17-0520.

    Article  CAS  PubMed  Google Scholar 

  77. Caretti, V., Hiddingh, L., Lagerweij, T., Schellen, P., Koken, P. W., Hulleman, E., van Vuurden, D., Vandertop, W. P., Kaspers, G. J., Noske, D. P., & Wurdinger, T. (2013). WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas. Molecular Cancer Therapeutics, 12(2), 141–150. https://doi.org/10.1158/1535-7163.MCT-12-0735.

    Article  CAS  PubMed  Google Scholar 

  78. Mueller, S., Hashizume, R., Yang, X., Kolkowitz, I., Olow, A. K., Phillips, J., Smirnov, I., Tom, M. W., Prados, M. D., James, C. D., Berger, M. S., Gupta, N., & Haas-Kogan, D. A. (2014). Targeting Wee1 for the treatment of pediatric high-grade gliomas. Neuro-Oncology, 16(3), 352–360. https://doi.org/10.1093/neuonc/not220.

    Article  CAS  PubMed  Google Scholar 

  79. Punt, J., & Cartmill, M. (1999). Diffuse brain stem glioma. Child's Nervous System, 15(5), 235–237. https://doi.org/10.1007/s003810050379.

    Article  PubMed  Google Scholar 

  80. Ratnam, K., & Low, J. A. (2007). Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology. Clinical Cancer Research, 13(5), 1383–1388. https://doi.org/10.1158/1078-0432.CCR-06-2260.

    Article  CAS  PubMed  Google Scholar 

  81. Baxter, P., Su, J., Li, X., Thomas, A. O., Billups, C., Thompson, P., et al. (2016). EPT-15A phase1/2 clinical trial of veliparib (ABT-888) and radiation followed by maintenance therapy with veliparib and temozolomide (TMZ) in patients with newly diagnosed diffuse intrinsic pontine glioma (DIPG): a Pediatric Brain Tumor Consortium interim report of phase II study. Neuro-Oncology, 18(suppl 3), 1–iii27. https://doi.org/10.1093/neuonc/now069.14.

    Article  Google Scholar 

  82. Su, J. M., Thompson, P., Adesina, A., Li, X.-N., Kilburn, L., Onar-Thomas, A., Kocak, M., Chyla, B., McKeegan, E., Warren, K. E., Goldman, S., Pollack, I. F., Fouladi, M., Chen, A., Giranda, V., Boyett, J., Kun, L., & Blaney, S. M. (2014). A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report. Neuro-oncology, 16(12), 1661–1668. https://doi.org/10.1093/neuonc/nou103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Zhou, Z., Luther, N., Ibrahim, G. M., Hawkins, C., Vibhakar, R., Handler, M. H., & Souweidane, M. M. (2013). B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma. Journal of Neuro-Oncology, 111(3), 257–264. https://doi.org/10.1007/s11060-012-1021-2.

    Article  CAS  PubMed  Google Scholar 

  84. Kaye, E. C., Baker, J. N., & Broniscer, A. (2014). Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis. CNS oncology, 3(6), 421–431. https://doi.org/10.2217/cns.14.47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Tang, X., Zhao, S., Zhang, Y., Wang, Y., Zhang, Z., Yang, M., Zhu, Y., Zhang, G., Guo, G., Tong, A., & Zhou, L. (2019). B7-H3 as a novel CAR-T therapeutic target for glioblastoma. Molecular therapy oncolytics, 14, 279–287. https://doi.org/10.1016/j.omto.2019.07.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Majzner, R. G., Theruvath, J. L., Nellan, A., Heitzeneder, S., Cui, Y., Mount, C. W., et al. (2019). CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 25(8), 2560–2574. https://doi.org/10.1158/1078-0432.CCR-18-0432.

    Article  Google Scholar 

  87. Greenberger, J. S., Cassady, J. R., & Levene, M. B. (1977). Radiation therapy of thalamic, midbrain and brain stem gliomas. Radiology, 122(2), 463–468. https://doi.org/10.1148/122.2.463.

    Article  CAS  PubMed  Google Scholar 

  88. Halperin, E. C. (1985). Pediatric brain stem tumors: patterns of treatment failure and their implications for radiotherapy. International Journal of Radiation Oncology, Biology, and Physics, 11(7), 1293–1298. https://doi.org/10.1016/0360-3016(85)90244-5.

    Article  CAS  Google Scholar 

  89. Panandiker, A. S. P., Wong, J. K., Nedelka, M. A., Gajjar, A., & Broniscer, A. (2014). Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma, (September 2013), (pp. 1180–1183). doi: https://doi.org/10.1002/pbc

  90. Cancer, A. C., Phase, G., Packer, R., Boyett, M., Ph, D., Zimmerman, R. A., … Ph, D. (1994). Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy.

  91. Sanford, R. A., & Carpio, R. D. E. L. (1993). ?? Clinical original contribution in children: a Pediatric Oncology Group study, 21(March).

  92. Zaghloul, M. S., Akoush, H., Ahmed, S., Tolba, M., Refaat, A., Youssef, A., Khateeb, N. E., & A. A. A. (2018). Hypofractionated radiation for pediatric diffuse intrinsic pontine glioma (DIPG): younger children have better survival. International Journal of Radiation Oncology, Biology, Physics, 101(4), 1008–1009.

    Article  Google Scholar 

  93. Tsang, D. S., & Laperriere, N. J. (2019). Re-irradiation for paediatric tumours. Clinical Oncology, 31(3), 191–198. https://doi.org/10.1016/j.clon.2018.10.003.

    Article  CAS  PubMed  Google Scholar 

  94. Lassaletta, A., Strother, D., Laperriere, N., Hukin, J., Vanan, M. I., Goddard, K., et al. (2018). Reirradiation in patients with diffuse intrinsic pontine gliomas: the Canadian experience. Pediatric Blood & Cancer, 65(6), e26988. https://doi.org/10.1002/pbc.26988.

    Article  Google Scholar 

  95. Evans, A., Hitrle, R., Ortega, J., Sposto, R., Wara, W., Wilson, C., et al. (1987). Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. Journal of Neurosurgery, 66, 227–233.

    Article  PubMed  Google Scholar 

  96. Jennings, B. M. T., Sposto, R., Boyett, J. M., Vezina, L. G., Holmes, E., Berger, M. S., et al. (2016). Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children’s Cancer Group. Journal of Clinical Oncology, 20(16), 3431–3437. https://doi.org/10.1200/JCO.2002.04.109.

    Article  CAS  Google Scholar 

  97. Allen, J., Siffert, J., Donahue, B., Nirenberg, A., Jakacki, R., Robertson, P., et al. (1999). A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer, 86, 1064–1069.

    Article  CAS  PubMed  Google Scholar 

  98. Broniscer, A., da Leite, C. C., Lanchote, V. L., Machado, T. M. S., & Cristófani, L. M. (2000). Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Journal of Clinical Oncology, 18(6), 1246–1253. https://doi.org/10.1200/JCO.2000.18.6.1246.

    Article  CAS  PubMed  Google Scholar 

  99. Cohen, K. J., Heideman, R. L., Zhou, T., Holmes, E. J., Lavey, R. S., Bouffet, E., & Pollack, I. F. (2011). with newly diagnosed diffuse intrinsic. Oncology Group, 13(4), 410–416.

    Google Scholar 

  100. Bailey, S., Howman, A., Wheatley, K., Wherton, D., Boota, N., & Pizer, B. (2013). Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy – results of a United Kingdom phase II trial CNS 2007 04. European Journal of Cancer, 49(18), 3856–3862. https://doi.org/10.1016/j.ejca.2013.08.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Ho, S. L., Singh, R., Zhou, Z., Lavi, E., & Souweidane, M. M. (2015). Toxicity evaluation of prolonged convection-enhanced delivery of small-molecule kinase inhibitors in naïve rat brainstem. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 31(2), 221–226. https://doi.org/10.1007/s00381-014-2568-3.

    Article  Google Scholar 

  102. Luther, N., Cheung, N.-K., Souliopoulos, E. P., Karempelas, I., Bassiri, D., Edgar, M. A., et al. (2010). Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38. Molecular Cancer Therapeutics, 9(4), 1039–1046. https://doi.org/10.1158/1535-7163.MCT-09-0996.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Souweidane, M. M., Occhiogrosso, G., Mark, E. B., & Edgar, M. A. (2004). Interstitial infusion of IL13-PE38QQR in the rat brain stem. Journal of Neuro-Oncology, 67(3), 287–293 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15164984.

    Article  PubMed  Google Scholar 

  104. Grasso, C. S., Tang, Y., Truffaux, N., Berlow, N. E., Liu, L., Debily, M.-A., Quist, M. J., Davis, L. E., Huang, E. C., Woo, P. J., Ponnuswami, A., Chen, S., Johung, T. B., Sun, W., Kogiso, M., du, Y., Qi, L., Huang, Y., Hütt-Cabezas, M., Warren, K. E., le Dret, L., Meltzer, P. S., Mao, H., Quezado, M., van Vuurden, D., Abraham, J., Fouladi, M., Svalina, M. N., Wang, N., Hawkins, C., Nazarian, J., Alonso, M. M., Raabe, E. H., Hulleman, E., Spellman, P. T., Li, X. N., Keller, C., Pal, R., Grill, J., & Monje, M. (2015). Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nature Medicine, 21(6), 555–559. https://doi.org/10.1038/nm.3855.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Hennika, T., Hu, G., Olaciregui, N. G., Barton, K. L., Ehteda, A., Chitranjan, A., et al. (2017). Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. PLoS One, 12(1), e0169485. https://doi.org/10.1371/journal.pone.0169485.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Helder, F., Felix, C., & Leite, O. (2014). Retrospective evaluation of the outcomes of children with diffuse intrinsic pontine glioma treated with radiochemotherapy and valproic acid in a single center, (pp. 261–266). doi: https://doi.org/10.1007/s11060-013-1280-6

    Article  PubMed  Google Scholar 

  107. Pollack, I. F., Stewart, C. F., Kocak, M., Poussaint, T. Y., Broniscer, A., Banerjee, A., Douglas, J. G., Kun, L. E., Boyett, J. M., & Geyer, J. R. (2011). A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro-Oncology, 13(3), 290–297. https://doi.org/10.1093/neuonc/noq199.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Carceller, F. (2019). Long-term survivors of diffuse intrinsic pontine glioma (DIPG): myth or reality. Translational Cancer Research, 8(20). https://doi.org/10.21037/tcr.2019.03.12.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Veldhuijzen van Zanten, S. E. M., Lane, A., Heymans, M. W., Baugh, J., Chaney, B., Hoffman, L. M., Doughman, R., Jansen, M. H. A., Sanchez, E., Vandertop, W. P., Kaspers, G. J. L., Vuurden, D. G., Fouladi, M., Jones, B. V., & Leach, J. (2017). External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry. Journal of Neuro-Oncology, 134(1), 231–240. https://doi.org/10.1007/s11060-017-2514-9.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Hoffman, L. M., Veldhuijzen van Zanten, S. E. M., Colditz, N., Baugh, J., Chaney, B., Hoffmann, M., et al. (2018). Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries. Journal of Clinical Oncology, 36(19), 1963–1972. https://doi.org/10.1200/JCO.2017.75.9308.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Rechberger, J. S., Lu, V. M., Zhang, L., Power, E. A., & Daniels, D. J. (2019). Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs. Child's Nervous System. https://doi.org/10.1007/s00381-019-04363-1.

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Eslam Maher and Mohamed Adel contributed equally to this work.

Authors and Affiliations

  1. Research Department, Children’s Cancer Hospital Egypt, Cairo, 57357, Egypt

    Wafaa M. Rashed & Eslam Maher

  2. Armed Forces College of Medicine (AFCM), Cairo, Egypt

    Mohamed Adel & Ossama Saber

  3. Radiotherapy Department, National Cancer Institute, Cairo University & Children’s Cancer Hospital, Cairo, 57357, Egypt

    Mohamed Saad Zaghloul

Authors
  1. Wafaa M. Rashed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eslam Maher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed Adel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ossama Saber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohamed Saad Zaghloul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wafaa M. Rashed or Mohamed Saad Zaghloul.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashed, W.M., Maher, E., Adel, M. et al. Pediatric diffuse intrinsic pontine glioma: where do we stand?. Cancer Metastasis Rev 38, 759–770 (2019). https://doi.org/10.1007/s10555-019-09824-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-019-09824-2

Keywords

Search

Navigation